Don’t miss the latest from industry at the 2022 AAD Annual Meeting

Explore nearly a dozen non-CME learning opportunities.


Getty Images 1313909794

The Industry Non-CME (INC) Program at the 2022 AAD Annual Meeting is your chance to learn about the latest from industry. INC Programs take place after scientific sessions in the evening and are solely developed and delivered by the sponsor. They do not qualify for continuing medical education credit.

Thursday, March 24   

Understanding Kinases: From the Role of TYK2 in Psoriasis Pathogenesis to the Functional Implications of Kinase Structures

Presented by: Bristol Myers Squibb, Platinum Sponsor, view in the Mobile App (+ logo recognition)

When: Thursday, March 24 | 7:00 p.m. program

Where: Momentum D | Omni Boston Hotel at the Seaport

Targeting New Pathways in Alopecia Areata: The Role of JAK/TEC Inhibitors

Although some may dismiss it as a mere cosmetic problem, alopecia areata (AA) affects 1-2% of the population and has a significant psychosocial impact on those who suffer from the disease, sometimes leading to social isolation, anxiety, and feelings of inauthenticity. Given the relatively small patient population and lack of approved agents, physicians are not up to date on the latest clinical trial data, in their ability to assess the impact on patients and to compare/contrast new and emerging therapies with established treatment options. This initiative will address these gaps to improve diagnosis, treatment, and management of patients with AA.

Presented by: Integrity Continuing Education (+ logo recognition)

Supported by: An educational grant from Pfizer Inc.

When: Thursday, March 24 | 6:30 p.m. registration | 7:00 p.m. program

Where: Momentum A, B, C | Omni Boston Hotel at the Seaport

For more information, please click here.

Friday, March 25 

Challenging AD Expectations: A New Therapy Option That Challenges Treatment Goals for Patients with Refractory, Moderate to Severe Atopic Dermatitis (AD) Who are Not Adequately Controlled with Other Systemic Drug Products

Presented by: AbbVie, Platinum Sponsor, view in the Mobile App (+ logo recognition)

When: Friday, March 25 | 6:30 p.m. registration | 7:00 p.m. program

Where: Momentum D | Omni Boston Hotel at the Seaport

The Impact of Immunotherapy in Patients with Advanced Non-melanoma Skin Cancer: Focusing in on Patient Identification and Treatment Optimization

Join Drs. Chrysalyn Schmults and Ann Silk as they discuss the clinical application of the novel immunotherapeutic agents for patients with non-melanoma skin cancer with personal perspectives from Dale Biggs, a patient who was treated for advanced cutaneous squamous cell carcinoma. As new options bring new hope for patients with non-melanoma skin cancer, come listen to how the experts in care implement personalized approaches in their practice to enhance patient outcomes and optimize treatment protocols.

Presented by: Answers in CME (AiCME) (+ logo recognition)

Supported by: An independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

When: Friday, March 25 | 6:30 p.m. registration | 7:00 p.m. program

Where: Pacific Grand Ballroom DE | Renaissance Boston Waterfront Hotel

Bench to Clinic: Innovations in Immunodermatology and Emerging Treatment Approaches

This is an opportunity to learn about the unmet needs in the management of patients with inflammatory skin diseases; the role of current and emerging cytokine-targeting pathways in psoriasis, atopic dermatitis, and hidradenitis suppurativa; and, the emerging treatment options and management approaches that may help address unmet needs in clinical practice.

Presented by: Janssen, Platinum Sponsor, view in the Mobile App (+ logo recognition)

When: Friday, March 25 | 6:30 p.m. registration | 7 p.m. Dinner | 7:30 p.m. program

Where: Momentum A, B, C | Omni Boston Hotel at the Seaport

Saturday, March 26 

Advances in Understanding Alopecia Areata and the Challenge of Special Body Areas in Psoriasis

This is an opportunity to learn about advances in understanding alopecia areata and a deep dive into psoriasis of the scalp, nails, genitals, and palmoplantar regions. Learn the latest information available on the pathogenesis, diagnosis, and assessment of alopecia areata and gain insight into the impact of psoriasis across challenging body areas.

Presented by: Eli Lilly and Company (+ logo recognition)

When: Saturday, March 26 | 6:30 p.m. registration | 7:00 p.m. program

Where: Pacific Grand Ballroom D | Renaissance Boston Waterfront Hotel

Advancements in Atopic Dermatitis: Understanding the Role of IL-13 and Clinical Decisions in Adult Atopic Dermatitis

Extraordinary advancements have been made in our understanding of the complex pathophysiology of atopic dermatitis.  The Type 2 cytokine IL-13 has been identified as having a central role in inflammation, itch, barrier dysfunction, and dysbiosis in atopic dermatitis patients. Understanding the pathogenesis can help inform treatment decisions for adult moderate to severe atopic dermatitis patients.

Presented by: LEO Pharma (+ logo recognition)

When: Saturday, March 26 | 6:30 p.m. registration | 7:00 p.m. program

Where: Momentum D | Omni Boston Hotel at the Seaport

Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options

This unique “Clinical Consult” live workshop from PeerView addresses questions and dilemmas faced by community physicians and patients with prurigo nodularis (PN) by providing practical guidance on how to effectively integrate the latest evidence and expert recommendations into real-world clinical scenarios. This activity will provide physicians with the necessary tools to effectively navigate the rapidly changing landscape for PN, using patient videos to convey key information regarding the burden of PN and optimal management strategies.

Presented by: PeerView Institute (+ logo recognition)

Supported by: An educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

When: Saturday, March 26 | 6:30 p.m. registration | 7:00 p.m. program

Where: Momentum A, B, C | Omni Boston Hotel at the Seaport

For more information, please click here.

Sunday, March 27

Taking the Flare Out of Atopic Dermatitis: The Role of Systemic Therapies in Children

In this live symposium, Drs. Amy Paller and Peter Lio provide their guidance on the role of systemic therapies for the management of children with atopic dermatitis. A patient advocate, Amy Chrnelich, will also discuss the burden of disease and the improvements seen with systemic treatment.

Presented by: Answers in CME (AiCME) (+ logo recognition)

Supported by: An independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

When: Sunday, March 27 | 6:30 p.m. registration | 7:00 p.m. program

Where: Momentum A, B, C | Omni Boston Hotel at the Seaport

Advances in Chronic Spontaneous Urticaria: Expert Insight on Translating Progress to Practice for Improved Symptom Control and Quality of Life

In this PeerView live “Master Class and Practicum” event, expert faculty will address current diagnostic/treatment strategies for chronic spontaneous urticaria (CSU) and the latest clinical data regarding emerging therapies, as well as the mechanisms of action, efficacy, and safety of these novel agents. They will provide practical guidance on how to effectively integrate the latest evidence and expert recommendations into real-world clinical scenarios, providing the necessary tools to effectively navigate the rapidly changing landscape for CSU.

Presented by: PeerView Institute (+ logo recognition)

Supported by: An educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

When: Sunday, March 27 | 6:30 p.m. registration | 7:00 p.m. program

Where: Atlantic ABC | Renaissance Boston Waterfront Hotel

For more information, please click here.

Under the Surface: Exploring the Pathophysiology and Unmet Needs in Patients with Psoriasis

This educational symposium will explore fresh insights into the pathophysiology of psoriasis and deep dive into the unmet needs that patients have and how this relates to their evolving expectations.

Presented by: UCB, Inc. (+ logo recognition)

When: Sunday, March 27 | 7:00 p.m. tegistration | 7:30 p.m. program

Where: Momentum D | Omni Boston Hotel at the Seaport

For more information, please click here.

Visit AAD DermWorld Meeting News Central for more articles.